BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2015

Nov 6, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2015-10-30

Reporting Person: Ajer Jeffrey Robert (SVP, Chief Commercial Of)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-10-30	Common Stock	A	26	$57.2635	Acquired	35631	Direct
2015-11-02	Common Stock	S	26	$117.56	Disposed	35605	Direct

Footnotes

F1: The reporting person is reporting the purchase of shares of the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of May 1, 2015 to October 31, 2015.

F2: Transaction made pursuant to a Rule 10b5-1 trading plan executed on December May 11, 2015.

F3: Due to administrative oversight the reported transaction, which should have been filed 11/4/2015 is being reported late.

F4: All shares sold at same price.